Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment

Human Pathology

Volumn 46, Issue 3, 2015, Pages 357-365

  D'Angelo, Sandra P ^a,b   Shoushtari, Alexander N ^a   Agaram, Narasimhan P ^a   Kuk, Deborah ^a   Qin, Li Xuan ^a   Carvajal, Richard D ^a,b   Dickson, Mark A ^a,b   Gounder, Mrinal ^a,b   Keohan, Mary Louise ^a,b   Schwartz, Gary K ^c   Tap, William D ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

CD3+,CD4+, CD8+, FOXP3+; Immunotherapy; PD 1; PD L1; Sarcoma; Tumor infiltrating lymphocyte

Indexed keywords

FORMALDEHYDE; PARAFFIN; PROGRAMMED DEATH 1 LIGAND 1; TRANSCRIPTION FACTOR FOXP3; CD274 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHONDROSARCOMA; CHORDOMA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DESMOID TUMOR; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HEMANGIOENDOTHELIOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; LIPOSARCOMA; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; MYOEPITHELIOMA; MYXOSARCOMA; NEUROECTODERM TUMOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREVALENCE; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; SOLITARY FIBROUS TUMOR; SPINDLE CELL SARCOMA; SYNOVIAL SARCOMA; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; TUMOR VOLUME; CD4 LYMPHOCYTE COUNT; CHEMISTRY; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; SARCOMA; YOUNG ADULT;

ADULT; AGED; ANTIGENS, CD274; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; SARCOMA; TUMOR MICROENVIRONMENT; YOUNG ADULT;

EID: 84924530574     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2014.11.001     Document Type: Article

References (24)

1. M.F. Brennan, C.R. Antonescu, and R.G. Maki Management of soft tissue sarcoma 2012 Springer New York
2. S. Rusakiewicz, M. Semeraro, and M. Sarabi Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors Cancer Res 73 2013 3499 3510
3. D. Berghuis, S.J. Santos, and H.J. Baelde Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression J Pathol 223 2011 347 357
4. S.W. Sorbye, T. Kilvaer, and A. Valkov Prognostic impact of lymphocytes in soft tissue sarcomas PLoS One 6 2011 e14611 10.1371/journal.pone.0014611
5. L. Zhang, and Y. Zhao The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road J Cell Physiol 211 2007 590 597
6. V.P. Balachandran, M.J. Cavnar, and S. Zeng Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido Nat Med 17 2011 1094 1100
7. K.E. de Visser, A. Eichten, and L.M. Coussens Paradoxical roles of the immune system during cancer development Nat Rev Cancer 6 2006 24 37
8. H. Dong, G. Zhu, K. Tamada, and L. Chen B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion Nat Med 5 1999 1365 1369
9. Y. Latchman, C.R. Wood, and T. Chernova PD-L2 is a second ligand for PD-1 and inhibits T cell activation Nat Immunol 2 2001 261 268
10. J.V. Ravetch, and L.L. Lanier Immune inhibitory receptors Science 290 2000 84 89
11. H. Dong, S.E. Strome, and D.R. Salomao Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion Nat Med 8 2002 793 800
12. J. Konishi, K. Yamazaki, and M. Azuma B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression Clin Cancer Res 10 2004 5094 5100
13. S.E. Strome, H. Dong, and H. Tamura B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma Cancer Res 63 2003 6501 6505
14. R.H. Thompson, M.D. Gillett, and J.C. Cheville Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target Proc Natl Acad Sci U S A 101 2004 17174 17179
15. S. Wintterle, B. Schreiner, and M. Mitsdoerffer Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis Cancer Res 63 2003 7462 7467
16. J.R. Kim, Y.J. Moon, and K.S. Kwon Tumor infiltrating PD1-positive lymphocytes and the expression of PD-L1 predict poor prognosis of soft tissue sarcomas PLoS One 8 2013 e82870 10.1371/journal.pone.0082870
17. S.L. Topalian, F.S. Hodi, and J.R. Brahmer Safety, activity, and immune correlates of anti-PD-1 antibody in cancer N Engl J Med 366 2012 2443 2454
18. J.D. Wolchok, H. Kluger, and M.K. Callahan Nivolumab plus ipilimumab in advanced melanoma N Engl J Med 369 2013 122 133
19. M.J. Gooden, G.H. de Bock, N. Leffers, T. Daemen, and H.W. Nijman The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis Br J Cancer 105 2011 93 103
20. L. Baitsch, P. Baumgaertner, and E. Devevre Exhaustion of tumor-specific CD8(+) T cells in metastases from melanoma patients J Clin Invest 121 2011 2350 2360
21. D. Moskophidis, F. Lechner, H. Pircher, and R.M. Zinkernagel Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells Nature 362 1993 758 761
22. R.S. Herbst, M.S. Gordon, and G.D. Fine A study of MPDL3280A, an engineered PD-L1 antibody in patients with locally advanced or metastatic tumors J Clin Oncol 31 2013 (Suppl):A3000
23. J.D. Powderly, H. Koeppen, and S.F. Hodi Biomarkers and associations with the clinical activity of PD-L1 blockade in a MPDL3280A study J Clin Oncol 31 2013 [Suppl.; abstr 3001]
24. T. Powles, N.J. Vogelzang, and G.D. Fine Inhibition of PD-L1 by MPDL3280A and clinical activity in pts with metastatic urothelial bladder cancer (UBC) J Clin Oncol 32 2014 (5 Suppl):A5011